From GlobeNewswire: 2024-06-10 22:00:00

The Global Cystatin C Assay Market is expected to grow from USD 270.6 million in 2023 to USD 525.9 million by 2033, at a CAGR of 6.87%. The market growth is driven by the rising prevalence of kidney diseases, benefits over traditional creatinine tests, technological advancements, and increasing use of point-of-care testing (POCT).

Value chain analysis of the cystatin C assay market involves stages from raw material procurement to end-use application. Factors such as regulatory compliance, cost management, and technological advancements play crucial roles in influencing market dynamics and providing effective diagnostic solutions.

In the Global Cystatin C Assay Market, the kits segment accounts for the largest market share due to innovations resulting in more sensitive and user-friendly kits. Blood samples dominate the market, providing a more precise and reliable evaluation of cystatin C levels. The diagnostics segment is also leading due to the rising prevalence of chronic kidney disease.

North America is expected to dominate the Cystatin C Assay Market from 2023 to 2033, driven by modern healthcare infrastructure and rising awareness of kidney diseases. Asia Pacific is witnessing the fastest growth due to increased healthcare awareness, economic expansion, and demographic transition towards an ageing population.

Key vendors in the Global Cystatin C Assay Market include Abbott, Roche Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, Randox Laboratories, DiaSys Diagnostic Systems, and others. Recent market developments include Gentian receiving IVDR certification for its Cystatin C and GCAL assays.

Market segmentation for the Cystatin C Assay Market includes analysis of product types, sample types, applications, and regions at global, regional, and country levels from 2023 to 2033. Other related reports include the Global Multi-omics Market and the Global Powered Mobility Devices Market.



Read more at GlobeNewswire: Global Cystatin C Assay Market Size To Worth USD 525.9